Concepedia

Robert E. Burrier

RE

Statistics

Publications

26

Citations

1.8K

H-Index

23

Active since

1983

Affiliations

Stemina Biomarker Discovery (United States)(Current)

University of California, Davis

Boston University

UCB Pharma (Belgium)

Cleveland Clinic

Robert E. Burrier is an author at Stemina Biomarker Discovery (United States) specializing in life sciences, pharmacology, and biochemistry.

Publications per year

1983–2023

26

Publications

26

2-Azetidinones as Inhibitors of Cholesterol Absorption

Duane A. Burnett, Mary Ann Caplen, Harry R. Davis et al. · Journal of Medicinal Chemistry · 1994 · 239 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +5

Metabolomics as a Tool for Discovery of Biomarkers of Autism Spectrum Disorder in the Blood Plasma of Children

Paul R. West, David G. Amaral, Preeti Bais et al. · PLoS ONE · 2014 · 153 citations · Full text

Life Sciences, Biochemistry, Autism Spectrum Disorders +15

Amino Acid Dysregulation Metabotypes: Potential Biomarkers for Diagnosis and Individualized Treatment for Subtypes of Autism Spectrum Disorder

Alan M. Smith, Joseph J. King, Paul R. West et al. · Biological Psychiatry · 2018 · 137 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

2-Azetidinone Cholesterol Absorption Inhibitors: Structure−Activity Relationships on the Heterocyclic Nucleus

John W. Clader, Duane A. Burnett, Mary Ann Caplen et al. · Journal of Medicinal Chemistry · 1996 · 133 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16

GR231118 (1229U91) and other analogues of the C-terminus of neuropeptide Y are potent neuropeptide Y Y1 receptor antagonists and neuropeptide Y Y4 receptor agonists

Eric M. Parker, Carol K Babij, Ambikaipakan Balasubramaniam et al. · European Journal of Pharmacology · 1998 · 115 citations

Medicine, Neuroscience, Pharmacology +14

1–5 of 26